Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Rectal Cancers”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableActive Not RecruitingNCT07038122
What this trial is testing

Reducing the Resection Range After Neoadjuvant Therapy for Locally Advanced Upper Rectal and Rectosigmoid Junction Cancers

Who this might be right for
Locally Advanced Rectal Carcinoma
Sixth Affiliated Hospital, Sun Yat-sen University 874
Early research (Phase 1)Study completedNCT00207051
What this trial is testing

BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies

Who this might be right for
Colorectal Cancer
Bristol-Myers Squibb 62
Very early researchUnknownNCT05886075
What this trial is testing

A Clinical Study on Oncolytic Virus Injection (R130) for the Treatment of Relapsed/Refractory Advanced Solid Tumors

Who this might be right for
Lung CancerBronchial CancerNon Small Cell Lung Cancer+9 more
Shanghai Yunying Medical Technology 24
Not applicableStudy completedNCT05396807
What this trial is testing

REVERT - taRgeted thErapy for adVanced colorEctal canceR paTients

Who this might be right for
Metastatic Colon Cancer
University of Rome Tor Vergata 106
Not applicableStudy completedNCT05534841
What this trial is testing

Assessment of Complete Response MRI Criterion After Neoadjuvant Therapy in Locally Advanced Rectal Cancer

Who this might be right for
Rectal Neoplasms
Centre Hospitalier Universitaire de Nīmes 99
Early research (Phase 1)Study completedNCT02959905
What this trial is testing

Treatment of Advanced Solid Tumors With TSA-CTL(Tumor Specific Antigen-Induced Cytotoxic T Lymphocytes)

Who this might be right for
Solid Cancer
BGI, China 11
Testing effectiveness (Phase 2)Ended earlyNCT02318901
What this trial is testing

Pembrolizumab and Monoclonal Antibody Therapy in Advanced Cancer

Who this might be right for
Advanced CancerBreast CancerGastric Cancer+2 more
Western Regional Medical Center 16
Early research (Phase 1)Looking for participantsNCT06400472
What this trial is testing

Sofe-M in Participants With Selected Advanced Solid Tumors

Who this might be right for
Ovarian NeoplasmsEndometrial NeoplasmsUterine Cervical Neoplasms+4 more
Eli Lilly and Company 575
Early research (Phase 1)Study completedNCT02041481
What this trial is testing

MEK Inhibitor MEK162 in Combination With Leucovorin Calcium, Fluorouracil, and Oxaliplatin in Treating Patients With Advanced Metastatic Colorectal Cancer

Who this might be right for
Recurrent Colon CancerRecurrent Rectal CancerStage IVA Colon Cancer+3 more
City of Hope Medical Center 26
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07175636
What this trial is testing

QL1706 With Short-Course Radiotherapy and Chemotherapy for MSS Rectal Cancer

Who this might be right for
Locally Advanced Rectal Cancer (LARC)Mismatch Repair-Proficient (pMMR) Rectal CancerNon-metastatic Rectal Cancer
Sun Yat-sen University 66
Early research (Phase 1)Ended earlyNCT05047536
What this trial is testing

KZR-261 in Subjects With Advanced Solid Malignancies

Who this might be right for
Advanced/Metastatic Solid Tumor
Kezar Life Sciences, Inc. 61
Large-scale testing (Phase 3)Study completedNCT01500993
What this trial is testing

Capecitabine in the Perioperative Treatment of Rectal Cancer

Who this might be right for
Rectal Cancer
Universitätsmedizin Mannheim 401
Testing effectiveness (Phase 2)Study completedNCT00551421
What this trial is testing

Pertuzumab and Cetuximab in Treating Patients With Previously Treated Locally Advanced or Metastatic Colorectal Cancer

Who this might be right for
Adenocarcinoma of the ColonAdenocarcinoma of the RectumRecurrent Colon Cancer+5 more
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT06940921
What this trial is testing

SBRT-LDRT-Cadonilimab for Advanced Gastric, Colorectal and Ovarian Cancers With Peritoneal Metastases

Who this might be right for
Advanced Gastric CancerAdvanced Colorectal CancerAdvanced Ovarian Cancer+1 more
Zhang Tao 26
Early research (Phase 1)Study completedNCT02935309
What this trial is testing

Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma

Who this might be right for
Rectal CancerRectal Adenocarcinoma
H. Lee Moffitt Cancer Center and Research Institute 20
Early research (Phase 1)Not Yet RecruitingNCT07358884
What this trial is testing

First in Human Study of QLS5316 in Solid Tumors

Who this might be right for
Solid TumorsColorectal CancerGastric Cancer or Gastroesophageal Junction Adenocarcinoma+2 more
Qilu Pharmaceutical Co., Ltd. 300
Testing effectiveness (Phase 2)UnknownNCT02602938
What this trial is testing

Aspirin on CTCs of Advanced Breast and Colorectal Cancer

Who this might be right for
Epithelial-Mesenchymal TransitionCirculating Tumor Cells
Zhejiang Provincial People's Hospital 40
Testing effectiveness (Phase 2)UnknownNCT04989855
What this trial is testing

Fruquintinib Plus PD-1 Antibody in pMMR / MSS Locally Advanced Rectal Cancer (LARC) With High Immune Score

Who this might be right for
Locally Advanced Rectal Cancer
Sun Yat-sen University 48
Testing effectiveness (Phase 2)UnknownNCT05426811
What this trial is testing

Regorafenib Plus Raltitrexed as Third-line Treatment in Advanced Colorectal Cancer Patients

Who this might be right for
RegorafenibRaltitrexedColorectal Neoplasms+1 more
China Medical University, China 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06014944
What this trial is testing

Short-course Radiotherapy Combined With Furoquintinib and PD-1 Monoclonal Antibody

Who this might be right for
Rectal Cancer
Changhai Hospital 30
Next Page